Clinical Biomarkers Market size worth $54,294.0 Million by 2032, at 8.73% CAGR | BIS Research
Among the various prevailing chronic diseases, cancer is the second leading cause of death globally. Other than cancer, infectious diseases such as HIV/AIDS, tuberculosis, malaria, and human papillomavirus (HPV) are also responsible for the increasing death rates, especially in developing countries. Emerging next-generation sequencing offers improvement in infectious disease diagnostics and...
0 Comments 0 Shares